Difference between revisions of "Bupropion-agomelatine"
From Psychiatrienet
| Line 1: | Line 1: | ||
| − | {{ Drugswitch <ref name="agoswitch"> {{SmPC Valdoxan}}</ref> | + | {{ Drugswitch <ref> name="agoswitch"> {{SmPC Valdoxan}}</ref> |
| from = bupropion | | from = bupropion | ||
| to = agomelatine | | to = agomelatine | ||
Revision as of 10:49, 4 August 2023
{{ Drugswitch [1] | from = bupropion | to = agomelatine | stop =
- Day 1: Stop bupropion.
- bupropion can be stopped abruptly for every dosage.[2]
| start =
- Day 1: simultaneously start administration of agomelatine in a dosage of 25 mg/day.[3]
- If necessary, increase dosage of agomelatine to 50 mg/day.
| info =
- No severe interactions are known.
}}
- ↑ name="agoswitch"> Template:SmPC Valdoxan
- ↑ Multidisciplinair document Afbouwen Overige Antidepressiva 2023
- ↑ McAllister-Williams RH et al. The use of antidepressants in clinical practice: focus on agomelatine. Hum Psychopharmacol. 2010 Mar 1;25(2):95-102
